In this episode, Dev Chatterji and Lois Lee discuss role the oral-beta lactams may serve in the treatment of Gram-Negative Rod bloodstream infections, the data behind the recommendation and identify the patients who may be ideal candidates for this therapy.
SPEAKERS
Lois Lee, PharmD, BCPPS, she/her is a board-certified pharmacist specializing in Pediatrics and Infectious Diseases. After completing her didactic training at the University of Maryland, she completed a postgraduate year 1 Residency and practiced as a NICU/PEDS pharmacist and Antimicrobial Stewardship lead at Frederick Health Hospital for many years. Dr. Lee is currently at Inova Fairfax Hospital where she is involved in the specialized care of patients with multi-drug resistant organisms and expanding antibiotic stewardship efforts across the institution.
Dev Chatterji, PharmD, BCPS, BCIDP, he/him is currently a clinical pharmacy specialist in Infectious Diseases at Inova Fairfax Medical Campus located in the Washington, DC metropolitan area. He is an active member of the multi-disciplinary antimicrobial stewardship team at Inova Fairfax and routinely participates in optimizing antimicrobial use at the institution as well as the Inova Health System. Dr. Chatterji graduated pharmacy school from the University of North Carolina- Chapel Hill and completed post graduate residency training at MedStar Georgetown University Hospital in Washington, DC.
Michael Kallenberger, PharmD, BCPS, DPLA, he/him graduated from University of Missouri – Kansas City in 2008 and completed his postgraduate year 1 residency at Truman Medical Centers- Kansas City in 2009. Upon residency graduation, he started the antimicrobial stewardship program at Truman Medical Centers and continued as the antimicrobial stewardship pharmacist until 2015. Michael then came to North Kansas City Hospital in 2015 to be a clinical pharmacist and took over the PGY1 residency program director role in 2021.